ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 35 filers reported holding ONCOCYTE CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,000 | -51.1% | 14,969 | -27.1% | 0.00% | – |
| Q4 2021 | $45,000 | -50.0% | 20,535 | -18.7% | 0.00% | – |
| Q3 2021 | $90,000 | -52.1% | 25,245 | -23.0% | 0.00% | – |
| Q2 2021 | $188,000 | +111.2% | 32,768 | +91.3% | 0.00% | – |
| Q1 2021 | $89,000 | +206.9% | 17,126 | +11.1% | 0.00% | – |
| Q2 2020 | $29,000 | -3.3% | 15,418 | +25.3% | 0.00% | – |
| Q1 2020 | $30,000 | +3.4% | 12,308 | -4.7% | 0.00% | – |
| Q4 2019 | $29,000 | -61.8% | 12,909 | -64.3% | 0.00% | – |
| Q3 2019 | $76,000 | +137.5% | 36,118 | +186.5% | 0.00% | – |
| Q2 2018 | $32,000 | – | 12,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $25,851,000 | 1.86% |
| Defender Capital, LLC. | 2,562,130 | $4,001,000 | 1.39% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $18,214,000 | 0.59% |
| Penbrook Management LLC | 578,150 | $861,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $492,000 | 0.52% |
| Orbimed Advisors | 3,493,800 | $5,206,000 | 0.08% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $112,000 | 0.07% |
| Fort Sheridan Advisors LLC | 135,000 | $201,000 | 0.06% |
| AWM Investment Company, Inc. | 241,867 | $360,000 | 0.05% |
| WEALTH EFFECTS LLC | 49,000 | $73,000 | 0.03% |